1424P Maintenance capecitabine plus ramucirumab after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma (OGA): Final analysis from the PLATFORM trial

• DOI: 10.1016/j.annonc.2024.08.1490
• Publication Date: 2024-09-17T20:32:58Z
• Authors: A. Gordon; Z. Rajan; C.Y.K. Fong; C. Peckitt; L. Satchwell; S. Cromarty; S. Kidd; K. Piadel; B. Leamon; O. Zhitkov; M. Davidson; J. Thompson; N.R. Maisey; S. Darby; T.S. Waddell; C. Morgan; A. Bradshaw; N. Starling; I. Chau; D. Cunningham
• Keywords: Ramucirumab